Mettler-Toledo International Inc. — Q3 2021 Form 10-Q
Business context and reporting period. The company supplies precision instruments, analytical solutions, inspection systems, and related services. This unaudited filing covers the quarter and nine months ended September 30, 2021; comparisons are with the corresponding 2020 periods.
Financial performance
| Metric | Q3 2021 | Q3 2020 | Nine months 2021 | Nine months 2020 |
|---|---|---|---|---|
| Net sales | $952.0 million | $807.4 million | $2,680.7 million | $2,147.2 million |
| Gross profit | $555.8 million | $469.6 million | $1,564.4 million | $1,242.0 million |
| Earnings before taxes | $247.6 million | $205.8 million | $663.4 million | $479.6 million |
| Net earnings | $203.7 million | $161.8 million | $538.1 million | $386.4 million |
| Diluted EPS | $8.71 | $6.68 | $22.86 | $15.92 |
| Operating cash flow | Not provided for quarter | Not provided for quarter | $667.7 million | $473.8 million |
- Q3 sales rose 18% in U.S. dollars and 16% in local currencies; nine-month sales rose 25% and 20%, respectively. PendoTECH contributed approximately 1% to sales in both periods.
- Gross margin was 58.4% in Q3 and 58.4% for the nine-month period, compared with 58.2% and 57.8%, respectively. Net margin was 21.4% in Q3 and 20.1% year to date, versus 20.0% and 18.0% in 2020.
- At September 30, cash was $183.7 million; total debt was $1,693.1 million, including $53.5 million current and $1,639.6 million long-term. The company reported $654.2 million of additional capacity under its revolving credit agreement. Current assets were $1,246.2 million and current liabilities $1,001.6 million.
- Nine-month capital expenditures were $69.8 million, versus $57.4 million. Investing cash outflow was $251.2 million, including $193.4 million for acquisitions. Financing cash outflow was $326.3 million, including $727.5 million of share repurchases, partly offset by net borrowing proceeds.
Material changes and notable items
- Growth was broad-based, led by laboratory and industrial products; China remained particularly strong. Q3 sales in food retailing declined 18% in U.S. dollars, which management attributed to project timing and component shortages.
- Product revenue grew 21% in Q3 and 28% year to date in U.S. dollars; service revenue grew 8% and 13%. Segment profit for all five reporting segments increased year over year in the periods presented.
- Margin improvement reflected sales volume and favorable price realization, partly offset by higher transportation and material costs and prior-year temporary cost savings. SG&A as a share of sales declined year to date.
- Long-term debt increased from $1,284.2 million at year-end 2020 to $1,639.6 million, with management citing acquisition funding among the drivers. The company issued $125 million of 2.83% senior notes in July and entered a new $1.25 billion credit agreement in June, maturing in 2026.
- The March acquisition of PendoTECH had an initial cash payment of $185 million, with up to $20 million of additional consideration and other post-closing amounts. In October, after the reporting period, the company acquired Scale-up Systems for $22.2 million initially, with up to EUR 3.0 million in additional amounts.
- The company repurchased 557,310 shares for $727.5 million during the first nine months, compared with 475,530 shares for $400.0 million in 2020. Remaining authorization was $2.3 billion at September 30.
Outlook, risks, and contingencies
- The filing provides no specific numerical earnings or sales guidance. Management said it expects operating cash flow, available credit, and cash balances to cover anticipated working capital and capital spending for the foreseeable future.
- Management described global supply-chain constraints, component and material shortages, supplier and transportation delays, and higher input and freight costs. These could adversely affect deliveries, sales, or profitability in future quarters.
- COVID-19-related uncertainty and changing market conditions remain risks. Management also flagged difficult prior-year comparisons in China for the remainder of 2021.
- Currency exposures include the Swiss franc, euro, and Chinese renminbi. The filing estimates that a 1% strengthening of the Swiss franc against the euro could reduce annual pretax earnings by approximately $1.8–$2.0 million; a 1% weakening of the renminbi against the U.S. dollar could reduce them by approximately $2.6–$2.8 million.
- The company was in compliance with debt covenants at September 30. Management did not expect pending legal and environmental proceedings, individually or collectively, to have a material adverse effect. No material risk-factor changes were reported.
- A $35.8 million Department of Defense grant is expected over two years to support domestic pipette-tip capacity and automation, offsetting future capital expenditures. The company also recognized $2.8 million of acquisition costs year to date and $2.7 million of restructuring charges.
Important facts for investors to verify
- Whether component availability, transportation costs, and material inflation affect delivery performance and margins.
- How much of reported sales and earnings growth reflects underlying demand, currency movements, acquisition contributions, and comparisons against pandemic-affected 2020 results.
- Debt levels, covenant headroom, interest expense, and the effect of further acquisitions and share repurchases on liquidity.
- Whether food-retailing weakness and difficult China comparisons persist, and the financial contribution of PendoTECH and Scale-up Systems.
- The assumptions and potential payments associated with acquisition earn-outs, as well as the timing and use of the federal grant.